Roque GW, Sarduy SS, Jaime FJC, Leyva PY

Language: Spanish
References: 22
Page: 1-10
PDF size: 564.40 Kb.

ABSTRACT

Introduction: Viral infections or latent-virus reactivation are frequent during the immunosuppressed cincition that follows hematopoietic stem-cell transplantation, and an important cause of complications, such as hemorrhagic cystitis, characterized by dysuria, urinary frequency, abdominal pain, and hematuria. The early appearance is associated with the administration of cytostatic drugs such as cyclophosphamide, and the late onset is associated with primary infection or reactivation of viruses such as cytomegalovirus, adenoviruses, or polyomaviruses such as BK and JC.
Objective: To describe the clinical characteristics, evolution and management of post-transplant hemorrhagic cystitis.
Clinical cases: The cases are presented of two patients with acute myeloid leukemia who developed hemorrhagic cystitis associated with viral infection by BK virus and cytomegalovirus after haploidentical transplantation with post-transplant cyclophosphamide. Viral hemorrhagic cystitis after hematopoietic transplantation in these patients was associated with severe immunosuppression, making it a potentially lethal complication. Both patients presented grade IV hemorrhagic cystitis and died despite treatment.
Conclusions: Haploidentical transplantation with the of post-transplant cyclophosphamide administration increases the possibility for donors of hematopoietic progenitor cells to patients without an identical HLA match, but the higher level of immunosuppression could increase the incidence of viral hemorrhagic cystitis.

REFERENCES

1. Lunde LE, Dasaraju S, Cao Q, Cohn CS, Reding M, Bejanyan N, et al. Hemorrhagic cystitis after allogeneic bone marrow transplantation: risk factors, graft source and survival. Bone Marrow Transplant. 2015 Nov;50(11):1432-7.

2. Uhm J, Hamad N, Michelis FV, Shanavas M, Kuruvilla J, Gupta V, et al. The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia, and severe acute GVHD. Bone Marrow Transplant. 2014 Dec;49(12):1528-34.

3. Padilla B, Bastida JM, Virseda AJ, Labrador J, Barrigón D, Abuin JM, et al. Hemorrhagic cystitis after bone marrow transplantation. Arch Esp Urol. 2014;67(2):167-73.

4. Gilis L, Morisset S, Billaud G, Ducastelle-Leprêtre S, Labussière-Wallet H, NicolinFE, et al. High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2014 May;49(5):664-70.

5. Copelan AR, Sanikommu SR, Trivedi JS, Butler C, Ai J, Ragon BK, et al. Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation. Biol Blood Marrow Transplant. 2019 Apr;25(4):785-90.

6. Shakeel D, Ali N, Shaikh UM, Adil NS. BK Polyomavirus hemorrhagic cystitis following allogeneic bone marrow transplant with haploidentical related donor: case reports from two patients. Adv Cytol Pathol. 2017;2(4):128-31.

7. Ruggeri A, Roth-Guepin G, Battipaglia G, Mamez A, Malard F, Gomez A. Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipient. Transpl Infect Dis. 2015 Oct;17(6):822-30.

8. Gander R, Asencio M, Guillen G, Rovo GF, Bolaños A, Pérez M. et al. Hemorrhagic cystitis after hematopoietic stem cell transplantation: a challenge for the pediatric urologist. J Pediatr Urol. 2018 Oct; 14(5):366-73.

9. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet. 1971 Jun;1(7712):1253-7.

10. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. Seroepidemiology of the human polyomaviruses. J Gen Virol. 2003 Jun;84(Pt6):1499-504.

11. Llerena Moreno D, Jaime Fagundo JC, Sarduy Sáez S, Quesada Laferté Y, Leiva Perdomo Y. Infecciones virales posteriores al trasplante hematopoyético. Reporte de tres casos. Rev Cub Hematol Inmunol Hemoter. 2017 [acceso 06/05/2019];33(S1):[aprox. 0 p.]. Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/666

12. Silva LP, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J, et al. Haemorragic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica. 2010 Jul;95(7):1183-90.

13. Cesaro S, Dalianis T, Rinaldo CH, Koskenuvo M, Pegoraro A, Einsele H, et al. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis stem cells transplant recipients. J Antimicrob Chemother. 2018 Jan;73(1):12-21.

14. Raj RV, Hari P, Paquini M, Epperla N, D´Souza A, Fenseke T. Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infection. Bone Marrow Transplant. 2016 Dec;51(12):1602-04.

15. Raiola A, Dominietto A, Ghiso A, Di Grazia C, Lamparelli T, Gualandi F, et al. Unmanipulated haploidentical BMT and posttransplantation cyclophosphamide for hematological malignancies after myeloablative conditioning. Biol Blood Marrow Transplant. 2013 Jan;19(1):117-22.

16. Rimondo A, Crocchiolo R, El-Cheikh J, Bramanti S, Granata A, Furst S, et al. The calcineurin inhibitor and conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transplant. 2017 Jan;52(1):135-7.

17. Sawinski D, Goral S. BK virus infection an update on diagnosis and treatment. Nephrol Dial Transplant 2015 Feb;30(2):209-17.

18. Philippe M, Ranchon F, Gilis L, Schwiertz V, Vantard N, Ader F, et al. Cidofovir in the Treatment of BK Virus Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2016 April;22(4):723-30.

19. Lee SS, Ahn JS, Jung SH, Ahn SY, Kim JY, Jang HC, et al. Treatment of BK virus-associated with low-dose intravenous cidofvir in patients undergoing allogeneic hematopoietic cell transplantation. Korean J Intern Med. 2015 Mar;30(2):212-8.

20. Ganguly N, Clough LA, Dubois LK, et al. Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. Transpl Infect Dis. 2010;1:406-11.

21. López D, Tan L, Alismail A. Hyperbaric Oxygen Therapy (HBOT) of an Adolescent Stem Cell Transplantation (SCT) Recipient with Hemorrhagic Cystitis, and BK Virus: A Rare Case Study in the United States. Am J Respir Crit Care Med. 2018;197:5664.

22. Kaur D, Khan SP, Rodriguez V, Arndt C, Claus P. Hyperbaric oxygen as a treatment modality in cyclophosphamide‐induced hemorrhagic cystitis. Pediatric Transplantation. 2018 Jun;22(4):e13171.